Tag: Crohn's disease

AzurRx BioPharma acquires US biotech company First Wave Bio for $229m

businessnewstoday- September 14, 2021 0

AzurRx BioPharma has signed a stock and cash deal worth $229 million to acquire Florida-based clinical-stage biotech company First Wave Bio. The consideration includes payments ... Read More

Amgen seeks FDA approval for infliximab biosimilar ABP 710

pharmanewsdaily- December 18, 2018 0

Amgen has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for ABP 710, a biosimilar candidate to Johnson & ... Read More

Hyrimoz EC approval : Novartis biosimilar of AbbVie Humira approved in EU

pharmanewsdaily- July 29, 2018 0

Hyrimoz EC approval : Novartis’ Sandoz has bagged approval for Hyrimoz (adalimumab), a biosimilar of AbbVie’s Humira (adalimumab), in Europe for all indications of the ... Read More